Activation of a cGAS-STING-mediated immune response predicts response to neoadjuvant chemotherapy in early breast cancer

MLA

Parkes, Eileen E., et al. Activation of a CGAS-STING-Mediated Immune Response Predicts Response to Neoadjuvant Chemotherapy in Early Breast Cancer. Nov. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.core.ac.uk....6d0b9160198373eeff3aac0c4a128464&authtype=sso&custid=ns315887.

APA

Parkes, E. E., Savage, K. I., Lioe, T., Boyd, C., Halliday, S., Walker, S. M., Lowry, K., Knight, L., Buckley, N. E., Grogan, A., Logan, G. E., Clayton, A., Hurwitz, J., Kirk, S. J., Xu, J., Sidi, F. A., Humphries, M. P., Bingham, V., Neo-DDIR Investigators, … McIntosh, S. A. (2021). Activation of a cGAS-STING-mediated immune response predicts response to neoadjuvant chemotherapy in early breast cancer.

Chicago

Parkes, Eileen E, Kienan I Savage, Tong Lioe, Clinton Boyd, Sophia Halliday, Steven M Walker, Keith Lowry, et al. 2021. “Activation of a CGAS-STING-Mediated Immune Response Predicts Response to Neoadjuvant Chemotherapy in Early Breast Cancer,” November. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.core.ac.uk....6d0b9160198373eeff3aac0c4a128464&authtype=sso&custid=ns315887.